JAGX - Jaguar Health - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

30.69M

Cash

11.67M

Avg Qtr Burn

-7.586M

Short % of Float

7.23%

Insider Ownership

18.74%

Institutional Own.

1.66%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Canalevia (crofelemer) Details Noninfectious diarrhea	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Crofelemer Details Noninfectious diarrhea, Chemotherapy induced nausea and vomiting	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Crofelemer powder Details Microvillus inclusion disease, Short bowel syndrome	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.